Related Experiment Video
Updated: Aug 23, 2025

Technique for Intranasal Administration of α-Synuclein Aggregates
Published on: November 8, 2024
Propagation of Distinct α-Synuclein Strains Within Human Reconstructed Neuronal Network and Associated Neuronal
Simona Gribaudo1,2,3,4, Luc Bousset5, Josquin Courte6,7
1Université Paris-Saclay, INSERM, I-Stem, AFM, Corbeil-Essonnes, France.
Researchers developed a human neuronal network on a chip to study Parkinson's disease (PD) and alpha-synuclein (α-Syn) strains. This model helps investigate α-Syn's prion-like properties and associated neuronal dysfunction in vitro.
Area of Science:
- Neuroscience
- Cell Biology
- Biochemistry
Background:
- Aggregated alpha-synuclein (α-Syn) is a key marker in Parkinson's disease (PD) and other synucleinopathies.
- Studying the prion-like spread of α-Syn in human neurons is crucial for understanding PD pathogenesis.
- Previous limitations in in vitro models hindered detailed investigation of α-Syn strains and neuronal interactions.
Purpose of the Study:
- To reconstruct a cortico-cortical human neuronal network on a microfluidic chip.
- To characterize the prion-like properties of different α-Syn strains using this model.
- To investigate neuronal dysfunctions and alterations caused by α-Syn exposure or endogenous nucleation.
Main Methods:
- Utilized advances in synthetic α-Syn assembly production and purification.
- Employed microfluidic devices for oriented and compartmentalized neuronal network construction.
- Differentiated human pluripotent stem cells (hPSCs) into specific neuronal subtypes for the model.
Main Results:
- Successfully reconstructed a functional human neuronal network on a chip.
- Characterized distinct prion-like properties of various α-Syn strains in vitro.
- Identified specific neuronal dysfunctions and molecular alterations upon α-Syn exposure.
Conclusions:
- The developed microfluidic neuronal network model is effective for studying α-Syn prion-like behavior.
- This model provides insights into the cellular and molecular mechanisms underlying synucleinopathies.
- Further research can leverage this platform to explore therapeutic interventions for Parkinson's disease.
More Related Videos
09:16Exogenous Administration of Microsomes-associated Alpha-synuclein Aggregates to Primary Neurons As a Powerful Cell Model of Fibrils Formation
Published on: June 26, 2018
10:26Monitoring Cell-to-cell Transmission of Prion-like Protein Aggregates in Drosophila Melanogaster
Published on: March 12, 2018
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Neural Regulation